Literature DB >> 7590473

Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection.

K A O'Hanlan1, S Kargas, M Schreiber, D Burrs, P Mallipeddi, T Longacre, M Hendrickson.   

Abstract

OBJECTIVE: To profile the incidence of mesenteric lymph node metastases in patients with ovarian carcinoma and metastases to the gastrointestinal tract in order to determine the optimal technique for surgical debulking.
METHODS: The slides and charts of all patients with ovarian carcinoma who had undergone bowel resection were retrospectively reviewed and follow-up information was obtained.
RESULTS: Of 100 separate bowel resections 44% had penetration of metastases to the muscularis, 18% had invasion through the submucosa, 4% had mucosal perforation, and two patients had clinical perforation. Fifty-five percent of all resections demonstrated lymph-vascular space invasion (LVSI). In the 33 specimens which included pathologic analysis of mesenteric lymph nodes, 79% had positive LVSI, which correlated with the presence of mesenteric lymph node metastases (P = 0.05) but not histologic grade (P = 0.20). When surgery was performed for secondary debulking, the frequency of mesenteric node metastasis was higher (P = 0.15). There was a trend for patients with positive mesenteric nodes to fail sooner (median survival, 20 months vs 32 months).
CONCLUSIONS: Because ovarian carcinoma metastases to the gastrointestinal tract are frequently associated with metastases to mesenteric lymph nodes, gynecologic oncology surgeons may wish to consider resection of the mesentery in a wedge fashion similar to current standards of resection for primary bowel carcinoma in cases in which a bowel resection is being performed with the intent to debulk to zero visible residual disease.

Entities:  

Mesh:

Year:  1995        PMID: 7590473     DOI: 10.1006/gyno.1995.0008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

Review 1.  Management of retroperitoneal lymph nodes in the treatment of ovarian cancer.

Authors:  Kimio Ushijima
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Rare recurrence of a rare ovarian stromal tumor with luteinized cells: a case report.

Authors:  Tazi El Mehdi; Ismail Essadi; Hind M'rabti; Hassan Errihani
Journal:  J Med Case Rep       Date:  2011-08-04

3.  BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.

Authors:  B T Paul; Z Blanchard; M Ridgway; W M ElShamy
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

4.  Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer.

Authors:  Kana Tanaka; Yoshifumi Shimada; Koji Nishino; Kosuke Yoshihara; Masato Nakano; Hitoshi Kameyama; Takayuki Enomoto; Toshifumi Wakai
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

5.  Colonic Metastasis Presenting as an Intraluminal Fungating Mass 8 Years After Surgery for Ovarian Cancer.

Authors:  Jeong Rye Kim; Bong Man Kim; You Me Kim; Won Ae Lee; Hwan Namgung
Journal:  Ann Coloproctol       Date:  2015-10-31

6.  Clinicopathological features and the value of differential Cytokeratin 7 and 20 expression in resolving diagnostic dilemmas of ovarian involvement by colorectal adenocarcinoma and vice-versa.

Authors:  Bharat Rekhi; Sophia George; Bhulaxmi Madur; R F Chinoy; Rajesh Dikshit; Amita Maheshwari
Journal:  Diagn Pathol       Date:  2008-09-18       Impact factor: 2.644

7.  Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer.

Authors:  Ming Chen; Ying Jin; Yalan Bi; Yan Li; Ying Shan; Lingya Pan
Journal:  J Cancer       Date:  2015-02-27       Impact factor: 4.207

8.  Synchronous ovarian carcinoma with colorectal metastases: an unusual presentation.

Authors:  Kafil Akhtar; Rana Sherwani; Afzaal Anees
Journal:  Clin Pract       Date:  2012-05-07

9.  Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastases.

Authors:  Angelo Di Giorgio; Maurizio Cardi; Daniele Biacchi; Simone Sibio; Fabio Accarpio; Antonio Ciardi; Tommaso Cornali; Marialuisa Framarino; Paolo Sammartino
Journal:  World J Surg Oncol       Date:  2013-03-09       Impact factor: 2.754

10.  Significance of lymphovascular space invasion in epithelial ovarian cancer.

Authors:  Koji Matsuo; Todd B Sheridan; Kiyoshi Yoshino; Takahito Miyake; Karina E Hew; Dwight D Im; Neil B Rosenshein; Seiji Mabuchi; Takayuki Enomoto; Tadashi Kimura; Anil K Sood; Lynda D Roman
Journal:  Cancer Med       Date:  2012-09-14       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.